Tumor Biology

, Volume 35, Issue 2, pp 1297–1305 | Cite as

COL1A1 polymorphism is associated with risks of osteosarcoma susceptibility and death

  • Maolin He
  • Zhe Wang
  • Jinmin Zhao
  • Yingbin Chen
  • Yang Wu
Research Article


Osteosarcoma is a life-threatening malignancy that often occurs in teenagers. Collagen type I alpha 1 (COL1A1) polymorphism is reportedly associated with the occurrence of several human diseases. However, the relationship between COL1A1 and osteosarcoma occurrence remains unknown, and there is no report about the prevalence of COL1A1 in osteosarcoma. The purpose of this study is to investigate the associations of COL1A1 polymorphism with the susceptibility and survival of osteosarcoma. The relative risk to develop osteosarcomas and the overall survival associated to COL1A1 polymorphism were investigated in a homogeneous group of 189 osteosarcomas patients. Correlations with overall survival and hazard ratios (HR) were also analyzed. CT genotype and C allele of COL1A1 at rs1061970, and CG genotype and G allele of COL1A1 at rs2075559 are associated with decreased susceptibility to osteosarcoma in the Chinese population. CC genotype and C allele of COL1A1 at rs1061970 are associated with nonmetastasis in patients. CC genotype and CT genotype of COL1A1 at rs1061970 are associated with lower risk of death. Metastasis was found to be an independent prognostic factor for survival. This study provides the first evidence for the association between COL1A1 polymorphism and osteosarcoma risk in Chinese and shows that COL1A1 polymorphism at rs1061970 has a prognostic value for overall survival in osteosarcoma patients.


COL1A1 Polymorphism Osteosarcoma Susceptibility Survival 



This research was supported by the National Natural Science Foundation of China (Grant No.81160323) and the Guangxi Innovative Program of Graduate Education (Grant No.YCSZ2012041).

Conflicts of interest



  1. 1.
    Ottaviani G, Jaffe N. The etiology of osteosarcoma. Cancer Treat Res. 2009;152:15–32. doi: 10.1007/978-1-4419-0284-9_2.PubMedCrossRefGoogle Scholar
  2. 2.
    Fuchs B, Zhang K, Schabel A, Bolander ME, Sarkar G. Identification of twenty-two candidate markers for human osteogenic sarcoma. Gene. 2001;278(1–2):245–52.PubMedCrossRefGoogle Scholar
  3. 3.
    Rosen G, Murphy ML, Huvos AG, Gutierrez M, Marcove RC. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer. 1976;37(1):1–11.PubMedCrossRefGoogle Scholar
  4. 4.
    Scotlandi K, Serra M, Nicoletti G, Vaccari M, Manara MC, Nini G, et al. Multidrug resistance and malignancy in human osteosarcoma. Cancer Res. 1996;56(10):2434–9.PubMedGoogle Scholar
  5. 5.
    Gorlick R. Current concepts on the molecular biology of osteosarcoma. Cancer Treat Res. 2009;152:467–78. doi: 10.1007/978-1-4419-0284-9_27.PubMedCrossRefGoogle Scholar
  6. 6.
    Foster L, Dall GF, Reid R, Wallace WH, Porter DE. Twentieth-century survival from osteosarcoma in childhood. Trends from 1933 to 2004. J Bone Joint Surg Br. 2007;89(9):1234–8. doi: 10.1302/0301-620X.89B9.19255.PubMedCrossRefGoogle Scholar
  7. 7.
    Gorlick R. Osteosarcoma: clinical practice and the expanding role of biology. J Musculoskelet Neuronal Interact. 2002;2(6):549–51.PubMedGoogle Scholar
  8. 8.
    Prockop DJ. Mutations that alter the primary structure of type I collagen. The perils of a system for generating large structures by the principle of nucleated growth. J Biol Chem. 1990;265(26):15349–52.PubMedGoogle Scholar
  9. 9.
    Ertugay OC, Ata P, Kalaycik Ertugay C, Kaya KS, Tatlipinar A, Kulekci S. Association of COL1A1 polymorphism in Turkish patients with otosclerosis. Am J Otolaryngol. 2013. doi: 10.1016/j.amjoto.2013.02.001.Google Scholar
  10. 10.
    Inamori Y, Ota M, Inoko H, Okada E, Nishizaki R, Shiota T, et al. The COL1A1 gene and high myopia susceptibility in Japanese. Hum Genet. 2007;122(2):151–7. doi: 10.1007/s00439-007-0388-1.PubMedCrossRefGoogle Scholar
  11. 11.
    Zhao YP, Wang H, Fang M, Ji Q, Yang ZX, Gao CF. Study of the association between polymorphisms of the COL1A1 gene and HBV-related liver cirrhosis in Chinese patients. Dig Dis Sci. 2009;54(2):369–76. doi: 10.1007/s10620-008-0340-9.PubMedCrossRefGoogle Scholar
  12. 12.
    Kostik MM, Smirnov AM, Demin GS, Nuskina M, Scheplyagina LA, Larionova VI. Genetic polymorphisms of collagen type I alpha1 chain (COL1A1) gene increase the frequency of low bone mineral density in the subgroup of children with juvenile idiopathic arthritis. EPMA J. 2013;4(1):15. doi: 10.1186/1878-5085-4-15.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Tilkeridis C, Bei T, Garantziotis S, Stratakis CA. Association of a COL1A1 polymorphism with lumbar disc disease in young military recruits. J Med Genet. 2005;42(7):e44. doi: 10.1136/jmg.2005.033225.PubMedCrossRefGoogle Scholar
  14. 14.
    Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet. 2001;29(2):229–32. doi: 10.1038/ng1001-229ng1001-229.PubMedCrossRefGoogle Scholar
  15. 15.
    Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science. 2002;296(5576):2225–9. doi: 10.1126/science.PubMedCrossRefGoogle Scholar
  16. 16.
    Zhang K, Deng M, Chen T, Waterman MS, Sun F. A dynamic programming algorithm for haplotype block partitioning. Proc Natl Acad Sci U S A. 2002;99(11):7335–9. doi: 10.1073/pnas.102186799.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2004;74(1):106–20. doi: 10.1086/381000.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Huang J, Lee C, Yu Q. A generalized log-rank test for interval-censored failure time data via multiple imputation. Stat Med. 2008;27(17):3217–26. doi: 10.1002/sim.3211.PubMedCrossRefGoogle Scholar
  19. 19.
    Ziegler A, Lange S, Bender R. Survival analysis: log rank test. Dtsch Med Wochenschr. 2007;132 Suppl 1:e39–41. doi: 10.1055/s-2007-959040.PubMedCrossRefGoogle Scholar
  20. 20.
    Provenzano F, D’Arrigo G, Zoccali C, Tripepi G. Cox regression analysis in epidemiological research. G Ital Nefrol. 2011;28(3):319–22.PubMedGoogle Scholar
  21. 21.
    Seigel DG. Cox regression analysis in clinical research. Arch Ophthalmol. 1990;108(6):888–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980;153:106–20.PubMedGoogle Scholar
  23. 23.
    Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res. 1986;204:9–24.PubMedGoogle Scholar
  24. 24.
    Naumov VA, Generozov EV, Solovyov YN, Aliev MD, Kushlinsky NE. Association of FGFR3 and MDM2 gene nucleotide polymorphisms with bone tumors. Bull Exp Biol Med. 2012;153(6):869–73.PubMedCrossRefGoogle Scholar
  25. 25.
    Hao T, Feng W, Zhang J, Sun YJ, Wang G. Association of four ERCC1 and ERCC2 SNPs with survival of bone tumour patients. Asian Pac J Cancer Prev. 2012;13(8):3821–4.PubMedCrossRefGoogle Scholar
  26. 26.
    Liu Y, Lv B, He Z, Zhou Y, Han C, Shi G, et al. Lysyl oxidase polymorphisms and susceptibility to osteosarcoma. PLoS ONE. 2012;7(7):e41610. doi: 10.1371/journal.pone.0041610.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Caronia D, Patino-Garcia A, Perez-Martinez A, Pita G, Moreno LT, Zalacain-Diez M, et al. Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study. PLoS ONE. 2011;6(10):e26091. doi: 10.1371/journal.pone.0026091.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Jin H, Stewart TL, Hof RV, Reid DM, Aspden RM, Ralston S. A rare haplotype in the upstream regulatory region of COL1A1 is associated with reduced bone quality and hip fracture. J Bone Miner Res. 2009;24(3):448–54. doi: 10.1359/jbmr.081111.PubMedCrossRefGoogle Scholar
  29. 29.
    Panagopoulos I, Mertens F, Lofvenberg R, Mandahl N. Fusion of the COL1A1 and USP6 genes in a benign bone tumor. Cancer Genet Cytogenet. 2008;180(1):70–3. doi: 10.1016/j.cancergencyto.2007.09.017.PubMedCrossRefGoogle Scholar
  30. 30.
    Koenig A, Mueller C, Hasel C, Adler G, Menke A. Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. Cancer Res. 2006;66(9):4662–71. doi: 10.1158/0008-5472.CAN-05-2804.PubMedCrossRefGoogle Scholar
  31. 31.
    Moro L, Arbini AA, Marra E, Greco M. Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation. J Biol Chem. 2005;280(23):22482–91. doi: 10.1074/jbc.M414091200.PubMedCrossRefGoogle Scholar
  32. 32.
    Savage SA, Mirabello L, Wang Z, Gastier-Foster JM, Gorlick R, Khanna C, et al. Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet. 2013;45(7):799–803. doi: 10.1038/ng.2645ng.2645.PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Amin N, van Duijn CM, Aulchenko YS. A genomic background based method for association analysis in related individuals. PLoS ONE. 2007;2(12):e1274. doi: 10.1371/journal.pone.0001274.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Shi H, Bevier M, Johansson R, Enquist-Olsson K, Henriksson R, Hemminki K, et al. Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer. Breast Cancer Res Treat. 2012;131(3):1039–47. doi: 10.1007/s10549-011-1826-2.PubMedCrossRefGoogle Scholar
  35. 35.
    Bustamante M, Nogues X, Enjuanes A, Elosua R, Garcia-Giralt N, Perez-Edo L, et al. COL1A1, ESR1, VDR and TGFB1 polymorphisms and haplotypes in relation to BMD in Spanish postmenopausal women. Osteoporos Int. 2007;18(2):235–43. doi: 10.1007/s00198-006-0225-8.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  • Maolin He
    • 1
  • Zhe Wang
    • 1
  • Jinmin Zhao
    • 2
  • Yingbin Chen
    • 1
  • Yang Wu
    • 1
  1. 1.Division of Spine and Osteopathy SurgeryThe First Affiliated Hospital of Guangxi Medical UniversityNanningChina
  2. 2.Department of Orthopedic Trauma and Hand SurgeryThe First Affiliated Hospital of Guangxi Medical UniversityNanningChina

Personalised recommendations